Innominds and SCIINV Biosciences launch AI tool to fight antibiotic resistance
AMRx diagnostic tool targets antimicrobial resistance without traditional cultures
Innominds has partnered with SCIINV…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Orchid Pharma receives DCGI approval for its antibiotic drug combination of Cefepime and…
Its reportedly company’s first invented and made-in-India drug
Orchid Pharma, has received Drugs Controller General of India…
Agomab receives FDA Orphan Drug Designation for AGMB-447 in idiopathic pulmonary fibrosis
AGMB-447 is an inhaled lung-restricted ALK5-inhibitor currently in a Phase 1 clinical trial
Agomab Therapeutics announced that…
STEER World appoints Vishal Mehta as Director of Sustainable Materials Program
Mehta brings 17 + years of experience and leadership
STEER World, recently announced the appointment of Vishal Mehta as the…
Revised pharmacovigilance guidance for human vaccines open for public consultation
Stakeholders are invited to provide feedback on CDSCO draft guidance within 15 days from the notice's issuance
On May 29, 2024…
Biosimilar market poised for significant growth in the coming years: GlobalData
As more biologics lose patent protection, the influx of biosimilars is set to expand, offering cost-effective alternatives and…
Jubilant Pharma completes stake sale in Sofie Biosciences
Merger with Trilantic Capital Partners leads to strategic disinvestment
Jubilant Pharma (JPL), has finalised the sale of its…
Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData
The drug will be the third prophylactic RSV vaccine to enter the US market following the launches of GSK’s Arexvy and Pfizer’s…
Torrent pharma enters into non – exclusive patent licensing agreement with Takeda Pharma
The company aims to commercialise its gastrointestinal drug in India
Torrent Pharmaceuticals recently announced that it has…
Biopharma industry remains mixed over EU reform proposals, finds GlobalData
Respondents’ opinions on the impact of EU reform proposals were mixed, with the percentage of participants expressing positive,…